Literature DB >> 18335479

Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents.

Susanne M Stieger1, Paul A Dayton, Mark A Borden, Charles F Caskey, Stephen M Griffey, Erik R Wisner, Katherine W Ferrara.   

Abstract

OBJECTIVES: Low-power multipulse contrast ultrasound imaging provides a promising tool to quantify angiogenesis noninvasively when used with contrast agents targeted to vascular markers expressed by the angiogenic endothelium. Targeted ultrasound contrast agents, with a diameter on the order of micrometers, cannot extravasate and therefore are targeted solely to receptors expressed by the vascular endothelium. The aim of this study was to evaluate the potential of a low-power multipulse imaging sequence, Cadence(TM) contrast pulse sequencing (CPS), combined with targeted contrast agents to quantify angiogenesis.
MATERIAL AND METHODS: Targeted microbubbles were prepared by conjugating echistatin via biotin-avidin linkage to the surface of a phospholipid microbubble shell. The density of echistatin present on the shell was confirmed with flow-cytometry and quantified by total fluorescence. The binding of targeted microbubbles was evaluated in vitro by quantifying the adherence of targeted microbubbles to rat aortic endothelial cells, compared with control (nontargeted) microbubbles. The circulation time and adherence of targeted microbubbles was evaluated in vivo in a Matrigel model in rats and compared with control microbubbles using CPS in addition to a destructive ultrasound pulse.
RESULTS: Using only the low-power CPS pulse, the echo intensity produced in the neovasculature of the Matrigel pellet was significantly greater with targeted microbubbles than with the control contrast agent (p < 0.001). Combining CPS with the destructive pulse, the processed image was significantly different in intensity (p < 0.001) and spatial extent between targeted and control agents (p < 0.001). When the morphology of the histological sample and ultrasound image correlated, the microvessel density count and the percentage of the circular area enhanced by ultrasound were correlated (p < 0.05).
CONCLUSION: Low-power multipulse imaging in combination with targeted echistatin-bearing microbubbles facilitated a noninvasive, quantitative evaluation of early angiogenesis during real-time imaging. The addition of high-intensity destructive pulses facilitated estimation of the spatial extent of angiogenesis. (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18335479     DOI: 10.1002/cmmi.224

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  36 in total

1.  scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis.

Authors:  Christopher R Anderson; Joshua J Rychak; Marina Backer; Joseph Backer; Klaus Ley; Alexander L Klibanov
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

Review 2.  Leveraging the power of ultrasound for therapeutic design and optimization.

Authors:  Charles F Caskey; Xiaowen Hu; Katherine W Ferrara
Journal:  J Control Release       Date:  2011-07-30       Impact factor: 9.776

3.  A stimulus-responsive contrast agent for ultrasound molecular imaging.

Authors:  Mark A Borden; Hua Zhang; Robert J Gillies; Paul A Dayton; Katherine W Ferrara
Journal:  Biomaterials       Date:  2007-10-30       Impact factor: 12.479

4.  Ultrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubble.

Authors:  Hua Zhang; Sarah Tam; Elizabeth S Ingham; Lisa M Mahakian; Chun-Yen Lai; Spencer K Tumbale; Tambet Teesalu; Neil E Hubbard; Alexander D Borowsky; Katherine W Ferrara
Journal:  Biomaterials       Date:  2015-04-16       Impact factor: 12.479

5.  High-resolution, high-contrast ultrasound imaging using a prototype dual-frequency transducer: in vitro and in vivo studies.

Authors:  Ryan Gessner; Marc Lukacs; Mike Lee; Emmanuel Cherin; F Stuart Foster; Paul A Dayton
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2010-08       Impact factor: 2.725

Review 6.  Advances in molecular imaging with ultrasound.

Authors:  Ryan Gessner; Paul A Dayton
Journal:  Mol Imaging       Date:  2010-06       Impact factor: 4.488

7.  Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.

Authors:  Christopher R Anderson; Xiaowen Hu; Hua Zhang; Jose Tlaxca; Anne-Emilie Declèves; Robert Houghtaling; Kumar Sharma; Michael Lawrence; Katherine W Ferrara; Joshua J Rychak
Journal:  Invest Radiol       Date:  2011-04       Impact factor: 6.016

8.  Ultrasonic imaging of endothelial CD81 expression using CD81-targeted contrast agents in in vitro and in vivo studies.

Authors:  Fei Yan; Xiang Li; Qiaofeng Jin; Juanjuan Chen; Robin Shandas; Junru Wu; Lu Li; Tao Ling; Wei Yang; Yun Chen; Xin Liu; Hairong Zheng
Journal:  Ultrasound Med Biol       Date:  2012-02-16       Impact factor: 2.998

9.  Assessment of molecular imaging of angiogenesis with three-dimensional ultrasonography.

Authors:  Jason E Streeter; Ryan C Gessner; James Tsuruta; Steven Feingold; Paul A Dayton
Journal:  Mol Imaging       Date:  2011-12       Impact factor: 4.488

Review 10.  Ultrasound of the prostate.

Authors:  Michael Mitterberger; Wolfgang Horninger; Friedrich Aigner; Germar M Pinggera; Ilona Steppan; Peter Rehder; Ferdinand Frauscher
Journal:  Cancer Imaging       Date:  2010-03-03       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.